RECK基因在恶性肿瘤浸润和转移中作用的研究进展
被引量:3
摘要
由于恶性肿瘤对周围组织的浸润和其它器官的转移,现有的治疗手段(手术、化疗、放疗)难以奏效,治疗困难,病死率高。Ahmedin等[1]在2010年一项基于国立癌症研究所、疾病预防控制中心、北美癌症登记协会和国家卫生统计中心数据的一篇报道中指出,
出处
《陕西医学杂志》
CAS
2011年第6期732-734,共3页
Shaanxi Medical Journal
参考文献19
-
1Ahmedin J,Rebecca S,Jiaquan Xu,et al.Cancer Statistics[J].Cancer J Clin,2010,60:277-0300.
-
2Norihiro T,Mitsuhiro T,Yasuhiro H,et al.Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorte survival after resection in patients with adenocarcinoma of the lung[J].Lung Cancer,2007,58:376-383.
-
3Makoto N,Junseo O,Rei T,et al.RECK:A novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling[J].Cancer Metastasis Res,2003,22(2 3):167-175.
-
4Takahashi C,Sheng Z,Horan TP,et al.Regulation of matrix metalloproteinase 9 and inhibition tumor invasion by the membraneanehored glycoprotein RECK[J].Proc Natl Acad Sci,1998,95(11):13221-13226.
-
5Michiko E,Shunya K,Rei T,et al.The membrane-anchored MMP-regulator RECK is a target of myogenic regulatory factors[J].Oncogene,2005,24:5850-5857.
-
6Anitha J,George T.The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis[J].Pathol Oncol Res,2001,7(1):14-23.
-
7Oh J,Takahashi R,Kondo S,et al.The membrane-Anchored MMP Inhibitor RECK Is a key regulator of extracellular matrix integrity and angiogenesis[J].Cell,2001,107(6):789-800.
-
8Akira O,Tomoko M,Kazuhiro M,et al.RECK Forms Cowbell-shaped Dimers and Inhibits Matrix Metalloproteinase-catalyzed Cleavage of Fibronectin[J].BIO CHEM,2009,284(6):3461-3469.
-
9Welm B,Mort J,Werb Z.Developmental biology:vasculogenesis is a wreck without RECK[J].Curr Biol,2002,12(6):209-211.
-
10罗湘玉,郭家龙,左顺庆,张军.非小细胞肺癌中RECK基因的表达及其与MMP-9的关系[J].现代肿瘤医学,2009,17(7):1246-1249. 被引量:3
二级参考文献12
-
1Takemoto N ,Tada M, Hida Y, et al. Low expression of reversion - inducing cysteine - rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarei- noma of the lung[ J]. Lung Cancer,2007,58 ( 3 ) :376 - 383.
-
2Furumoto K, Arii S, Moil A, et al. RECK gene expression in hepatocellular carcinoma: correlation with invasion - related clinicopathological factors and its clinical significance. Reverse - inducing - cysteine - rich protein with Kazal motifs [ J ]. Hepatology, 2001,33 (1) :189 -195.
-
3Asano T, Tada M, Cheng S, et al. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma[ J]. J Surg Res,2008,146( 1 ) :32 -42.
-
4Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis [ J]. Cancer Metastasis Rev ,2006,25 ( 1 ) :9 - 34.
-
5St - Pierre Y, Couillard J, Van Themsche C. Regulation of MMP - 9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases [ J ]. Expert Opin Ther Targets,2004,8 (5) :473 - 489.
-
6Leinonen T, Pirinen R, Bohm J, et al. Expression of matrix metalloproteinases 7 and 9 in non - small cell lung cancer. Relation to clinicopathological factors, beta--catenin and prognosis [ J ]. Lung Cancer,2006,51 (3) :313 -321.
-
7Oh J, Takahashi R, Kondo S, et al. The membrane - anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis [ J ]. Cell,2001,107 (6) :789 - 800.
-
8Rydlova M, Holubec L Jr, Ludvikova M Jr, et al. Biological activity and clinical implications of the matrix metalloproteinases[ J ]. Anticancer Res,2008,28 (2) : 1389 - 1397.
-
9Meng N,Li Y,Zhang H,et al. RECK,a novel matrix metalloproteinase regulator[ J ]. Histol Histopathol,2008,23 (8) : 1003 - 1010.
-
10Takahashi C, Sheng Z, Horan TP, et al. Regulation of matrix metalloproteinase - 9 and inhibition of tumor invasion by the membrane -anchored glycoprotein RECK [ J ]. Proc Nat Acad Sci USA, 1998,95(22) :13221 - 13226.
同被引文献37
-
1Clark JC,Thomas DM,Choong PF, et aI.RECK-a newlydiscovered inhibitor of metastasis with prognostic significance in multiple forms of cancer[J].Cancer Metastasis Rev,2007,26(3-4):675-683.
-
2Sledge GW.Implications of the new biology for the rapy in breast cancer[J].Semin Onco1,1996,23(1 Supp12):76-81.
-
3Basset P, Okada A,Chenard MP.Matalloproteinase as stromaleffectors of human carcinoma progression: therapeutic implications[J].Matrix Bio,1997,15(8-9): 535- 540.
-
4Ones JL,Glyrm P, Walker RA.Expression of MMP-2 and MMP-9.Their inhibit ors,and the activator MTI-MMP in primary breast carcinomas [J].Pathol, 1999,189(2): 161-168.
-
5Nakopoulou L,Tsirmpa I,Alexandrou P, et al.MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival[J].Breast Cancer ResTreat, 2003,77(2): 145-155.
-
6B0rriruicwanit K,Lafleur MA,Mercurif A,et al.The type 1 collagen induction of MTI- MMP- mediated MMP- 2 activation is repreased by alpha Vbeta3 integrin in human breast cancer eells[J].Matrix Biology,2007,26(4)291-305.
-
7Nawrocki B,Polette M,Marchand V, et al.Expression of matrix matalIoproteinase and their inhibitors in human bronchopulmonary carcinomas- Quantificative and morphological analysis[J].Int J Cancer,1997,72: 556-564.
-
8Mori M,Mimori K, Shlraishi T, et al.Analysis of MT1-MMP and MMP-2 expression in human gastric cancers[J].Int J Cancer, 1997,74.316-321.
-
9Ellenrieder V, Alber B,Lacher U,et al.Role of MT-MMPs and MMP-2 in pancreatic cancer progression[J].Int J Cancer, 2000,85:14-20.
-
10Nakamura H, Ueno H, Yamashita K,et al.Erdaanced production and activation of progelatinase A mediated by membrane-typel matrix metalloproteinase in human papillary thyroid careinomas[J].Cancer Res,1999,59: 463- 467.
引证文献3
-
1阿依努尔.艾比布拉,尹小朋,龚忠诚,刘慧,凌彬,克热木.阿巴斯,胡露露,宁晓婷,杨萌,陈青立,林兆全.基质金属蛋白酶-2、14及RECK基因在涎腺多形性腺瘤的初发、复发及恶变中的表达及意义[J].中国美容医学,2015,24(5):40-46.
-
2尹小朋,凌彬,龚忠诚,王冰,刘慧,陈青立,杜柏兴,阿依努尔.艾比布拉,林兆全.RECK基因与基质金属蛋白酶-2、9在腮腺多形性腺瘤中的表达及意义[J].新疆医学,2015,45(12):1733-1737. 被引量:3
-
3尹小朋,辜文妍,李红,周昱川,龚忠诚.涎腺多形性腺瘤细胞中RECK和MMP-9的表达及与肿瘤复发的相关性分析[J].现代肿瘤医学,2021,29(5):765-768. 被引量:3
二级引证文献6
-
1李丽.腮腺多形性腺瘤患者围术期炎性应激变化的研究[J].中国医药指南,2016,14(20):146-146.
-
2唐瑞平,伍爱民,郑本强,李敬,邓凌,何红.基质金属蛋白酶-2、CD147在腮腺多形性腺瘤中的表达研究[J].转化医学电子杂志,2016,3(12):22-24.
-
3王婧,朱豫.泪腺上皮性肿瘤分子生物学进展[J].国际眼科纵览,2018,42(4):269-273. 被引量:3
-
4王宝,赵晖,贾春祎,赵鑫,邹勤光,孙少林,王启文.MMP-9、Myosin-9及LGR4在老年非小细胞肺癌中表达及临床意义[J].中国老年学杂志,2023,43(1):37-41. 被引量:2
-
5侯翌杰,何志超,夏苗.唾液腺腺样囊性癌患者的MAPK、MMP-2和MMP-9及CD147表达和价值[J].系统医学,2023,8(14):1-4.
-
6尹治清,陆晓.经皮胆管穿刺引流介入对肝门部胆管癌患者肝功能恢复、肿瘤标志物及血清MMP-9的影响[J].罕少疾病杂志,2024,31(2):63-64.
-
1邵风菊.9413例恶性肿瘤病人统计分析[J].浙江临床医学,2002,4(10):797-798.
-
2陈刚,陈汉华,韦佩坤.原发性肝癌851例随访结果分析[J].广西医科大学学报,1995,12(1):113-114.
-
3孙光.应更加重视泌尿系统肿瘤的临床研究[J].中华外科杂志,2009,47(10):721-722.
-
4解永松,贾淞淦,李连宏.微RNA-34a与乳腺癌相关信号通路[J].中华乳腺病杂志(电子版),2014,8(5):50-52. 被引量:1
-
5支修益,吴一龙,马胜林,王天佑,王长利,王洁,石远凯,卢铀,刘伦旭,刘德若,陈东红,杨跃,杜祥,步宏,周清华,姜格宁,韩宝惠,程刚,程颖,焦顺昌.原发性肺癌诊疗规范(2011年版)[J].中国肺癌杂志,2012,15(12):677-688. 被引量:254
-
6邵志敏.乳腺定期筛查,从30岁开始[J].康复,2016,0(4):51-52.
-
7贺天宝.上海每年新发癌症近5万例[J].现代领导,2013(2):46-46.
-
8王永兰,朱建勇.肺癌组织中相关标志物表达的变化及临床意义[J].中华肺部疾病杂志(电子版),2015,8(4):41-43. 被引量:1
-
9每百名上海人中有一名癌症患者[J].致富天地,2006(6):25-25.
-
10陈可欣,何敏,董淑芬,王继芳.天津市女性乳腺癌发病率死亡率和生存率分析[J].中华肿瘤杂志,2002,24(6):573-575. 被引量:78